Return to content in this issue

Off-label Use of Mepolizumab: A Potential Therapeutic Option for Eosinophilic Cystitis

Wang G1, Zhuo N², Liu Z<sup>1

1</sup>Department of Rheumatology and Immunology, The Second Affiliated Hospital of Soochow University, Suzhou, China
²Department of Nephrology, The Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou Municipal Hospital, Suzhou, China

J Investig Allergol Clin Immunol 2024; Vol. 34(4)
doi: 10.18176/jiaci.0973

• Abstract
• Supplemental Materials

Key words: Eosinophilic cystitis, Mepolizumab

	Title	Type	Size
	doi10.18176_jiaci.0973_supplemental-materials-figure.pdf	pdf	332.00 Kb